A new clinical trial by the University of California, Davis School of Veterinary Medicine is focusing on dogs with pulmonic stenosis, one of the most common congenital heart defects in dogs.
The researchers involved in the clinical trial will study the effects of butorphanol and atenolol on heart function and assessment of disease severity.
Specifically, the clinical trial seeks dogs diagnosed with pulmonic stenosis with a pressure gradient >50mmHg and that are free of any other concurrent cardiac disease and not currently taking any cardiac medications.
All costs associated with the study will be paid for by UC Davis.
Results from the trial, the university noted, will allow veterinarians to better understand and guide medical care for dogs with pulmonic stenosis.
For additional details, visit the website.